Eli Lilly is already one of the leading players in the obesity drug segment, and the new data show that the company can raise the efficacy bar even higher
Some participants in the combined intervention group experienced mild abdominal discomfort and mild nausea or headache

nurses stepping off the picket lines amid mediation02:07 | July 14, 2026 Music choices reshape your brain, research reveals01:38 | July 14, 2026 As birthrate hits record low, South Koreans seek love at Buddhist temple retreat02:36 | July 13, 2026 New tick-borne illness on the rise in Canada02:09 | July 13, 2026 Health Matters: Ontario and Manitoba to get hammered by heat wave02:05 | July 13, 2026 Health Matters: Injury-related hospitalizations on the rise in Canada02:04 | July 10, 2026 Ebola outbreak continues to spread in Eastern Congo01:39 | July 9, 2026 Katie Couric reveals she suffered from bout of temporary amnesia02:06 | July 9, 2026 Conservative MP calls for public participation in COVID-19 vaccine injury inquiry03:37 | July 9, 2026 Health Matters: Alberta auditor general to finish health probe by end-of-year02:19 | July 9, 2026 New cancer cases could nearly double by 2050: WHO report02:02 | July 8, 2026 Semaglutide associated with blindness risk, study suggests01:52 | July 4, 2024 Alberta introducing out-of-pocket, private pay cancer test program01:54 | 6 hours ago 1 in 10 E.R

Per the company's published terms of use, the platform itself is not a healthcare provider
Coscia and his team are here to guide you every step of the way
Accessed March 18, 2026.